This is the authors' abstract. We don't add key points for this paper.
Genome editing with engineered nucleases, a powerful tool for understanding biological function and revealing causality, was built in a joint effort by academia and industry in 1994-2010. Use of CRISPR-Cas9 is the most recent (2013-), and facile, implementation of the resulting editing toolbox. Principles and methods of genome editing from the pre-CRISPR era remain relevant and continue to be useful.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fyodor D. Urnov (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: